Aoxing Biotechnology Int'l. Co. Ltd Sustainability Profile
Aoxing Biotechnology International Co. Ltd., commonly referred to as Aoxing Biotech, is a leading player in the biotechnology sector, headquartered in China. Established in 2001, the company has made significant strides in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of pain management and addiction treatment. With a strong operational presence across Asia and expanding into global markets, Aoxing Biotech is renowned for its unique formulations and high-quality standards. The company’s core offerings include a range of pharmaceutical products that leverage advanced biotechnological processes, setting them apart in a competitive landscape. Aoxing Biotech's commitment to research and development has positioned it as a trusted name in the industry, contributing to its notable achievements and market leadership.
DitchCarbon Score
How does Aoxing Biotechnology Int'l. Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aoxing Biotechnology Int'l. Co. Ltd's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aoxing Biotechnology Int'l. Co. Ltd's reported carbon emissions
Aoxing Biotechnology Int'l. Co. Ltd, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. Given the absence of emissions data and reduction initiatives, Aoxing Biotechnology's climate strategy appears to be undeveloped compared to industry standards. This context highlights the importance of establishing measurable targets and transparent reporting to align with global climate commitments and enhance sustainability practices within the biotechnology sector.
How Carbon Intensive is Aoxing Biotechnology Int'l. Co. Ltd's Industry?
How Carbon Intensive is Aoxing Biotechnology Int'l. Co. Ltd's Location?
Aoxing Biotechnology Int'l. Co. Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aoxing Biotechnology Int'l. Co. Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
